Comparison of an Affibody-based Molecular Probe and (18)F-FDG for Detecting HER2-Positive Breast Cancer at PET/CT. Guo X, Zhou N, Liu J, Ding J, et al. Radiology 2024;311:e232209.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guo X, Zhou N, Liu J, Ding J, et al. Comparison of an Affibody-based Molecular Probe and (18)F-FDG for Detecting HER2-Positive Breast Cancer at PET/CT. Radiology 2024;311:e232209.
PMID: 38888484